Release Date: 23/02/22 13:30 Summary: Farmaforce and AFT Pharmaceuticals Partnership Price Sensitive: Yes Download Document 292.73KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status